Search research articles
Contact Us
Filters
Showing results (51-60 of 134) with videos related to
Page
of 14
Sort By:
Clinical Pharmacology and Therapeutics
|
June 1, 1985
Metabolite cumulation during chronic propafenone dosing in arrhythmia
R E Kates, Y G Yee, R A Winkle
The American Journal of Cardiology
|
January 1, 1981
Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide
R A Winkle, P Jaillon, R E Kates, et al.
The American Journal of Physiology
|
October 1, 1980
Time dependency of ventricular fibrillation thresholds determined using trains of stimuli
R A Winkle, P Jaillon, J C Griffin, et al.
Circulation Research
|
May 1, 1980
The relationship between the repetitive extrasystole threshold and the ventricular fibrillation threshold in the dog. Non-parallel changes following pharmacological intervention
P Jaillon, I Schnittger, J C Griffin, et al.
Southern Medical Journal
|
October 1, 1972
Neisseria meningitidis cellulitis
Y Ploy-Song-Sang, R A Winkle, J P Phair
American Heart Journal
|
January 1, 1982
Frequency response characteristics of ambulatory ECG monitoring systems and their implications for ST segment analysis
D A Bragg-Remschel, C M Anderson, R A Winkle
American Heart Journal
|
January 1, 1987
The relationship between successful defibrillation and delivered energy in open-chest dogs: reappraisal of the "defibrillation threshold" concept
J M Davy, E S Fain, P Dorian, et al.
American Heart Journal
|
November 1, 1981
Malignant ventricular tachyarrhythmias associated with the use of encainide
R A Winkle, J W Mason, J C Griffin, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1980
Intravenous N-acetylprocainamide disposition kinetics in coronary artery disease
R E Kates, P Jaillon, D S Rubenson, et al.
The American Journal of Cardiology
|
April 1, 1983
Possible contribution of encainide metabolites to the long-term antiarrhythmic efficacy of encainide
R A Winkle, F Peters, R E Kates, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 134) with videos related to
Sort By:
Page
of 14
Clinical Pharmacology and Therapeutics
|
June 1, 1985
Metabolite cumulation during chronic propafenone dosing in arrhythmia
R E Kates, Y G Yee, R A Winkle
The American Journal of Cardiology
|
January 1, 1981
Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide
R A Winkle, P Jaillon, R E Kates, et al.
The American Journal of Physiology
|
October 1, 1980
Time dependency of ventricular fibrillation thresholds determined using trains of stimuli
R A Winkle, P Jaillon, J C Griffin, et al.
Circulation Research
|
May 1, 1980
The relationship between the repetitive extrasystole threshold and the ventricular fibrillation threshold in the dog. Non-parallel changes following pharmacological intervention
P Jaillon, I Schnittger, J C Griffin, et al.
Southern Medical Journal
|
October 1, 1972
Neisseria meningitidis cellulitis
Y Ploy-Song-Sang, R A Winkle, J P Phair
American Heart Journal
|
January 1, 1982
Frequency response characteristics of ambulatory ECG monitoring systems and their implications for ST segment analysis
D A Bragg-Remschel, C M Anderson, R A Winkle
American Heart Journal
|
January 1, 1987
The relationship between successful defibrillation and delivered energy in open-chest dogs: reappraisal of the "defibrillation threshold" concept
J M Davy, E S Fain, P Dorian, et al.
American Heart Journal
|
November 1, 1981
Malignant ventricular tachyarrhythmias associated with the use of encainide
R A Winkle, J W Mason, J C Griffin, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1980
Intravenous N-acetylprocainamide disposition kinetics in coronary artery disease
R E Kates, P Jaillon, D S Rubenson, et al.
The American Journal of Cardiology
|
April 1, 1983
Possible contribution of encainide metabolites to the long-term antiarrhythmic efficacy of encainide
R A Winkle, F Peters, R E Kates, et al.
Page
of 14